KATHLEEN NGUYEN: Open Payments
NPI 1245814961 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $420 · 2025 $891
Food & beverage: $877Travel & lodging: $14
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $162 |
| SCPHARMACEUTICALS INC. | 2 | $150 |
| Alnylam Pharmaceuticals Inc. | 1 | $138 |
| Bolton Medical Inc | 2 | $135 |
| Novo Nordisk Inc | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
Products named: FUROSCIX, XIFAXAN, ONPATTRO, AUSTEDO XR, METACROSS OTW, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, ENTYVIO, TERLIVAZ.
Industry payments across TX — which companies pay providers there.
